Menu
Amrit Mahotsav Logo
International Year of Cooperatives Logo

Important Document

Important Document

Sr. No. Title Details
301 Ensuring compliance of the price capping of the Coronary Stents along with maintaining its uninterrupted supply -regarding
302 Ensuring compliance of the price capping of the Primary Knee and Revision Knee along with maintaining its uninterrupted supply -regarding
303 Hiring of Senior Consultants and Consultant in NPPA on contract basis
304 Message of Honorable Secretary Department of Pharmaceuticals on Hindi Day
305 Report of Department of Pharmaceuticals on Swachhata Pakhwada During 16-31st August 2017
306 Major achievements during August 2017 IC Section
307 Message from Honorable Minister (C&F) on Swachhta Pakhwada
308 Message from Honorable MOS (C&F) on Swachhta Pakhwada
309 FAQs on GST on drugs and Pharmaceuticals
310 3rd India Pharma Awards and Medical Device Awards
311 Minutes of 28th Steering Committee Meeting
312 Shortage of Pencillamine medicine used for treatment of Wilsons disease - regarding
313 Appointment of Part - time CVO in Department of Pharmaceuticals
314 Constitution of GST Facilitation Cell
315 Application for the post of Director, Niper, Hyderabad
316 Application form of Technical and Legal Consultant on contract basis
317 Hiring of Technical consultant and Legal consultant on contract- reg.
318 Hiring of Technical consultant and Legal consultant on contract- reg.
319 Implementation of prices fixed and notified under the provisions of DPCO, 2013 - reg.
320 Minutes of the Meeting held on 09.05.2017 in the Department of Pharmaceuticals regarding preparation of Calendar of Events for organizing Conferences/Seminars/Workshops under Pharmaceutical Promotion and Development Scheme- PPDS
321 Meeting regarding Grant-in-aid under Pharmaceuticals Promotion & Development Scheme (PPDS)
322 Composition of NPPA Authority- Regarding
323 Shortage of Pencillamine medicine used for treatment of Wilsons disease - regarding
324 Fixation of ceiling price of a scheduled formulation under Para 4 of Drugs (Prices Control) Order, 2013 (DPCO, 2013) - regarding.
325 Submission of the detailed agreement/contract between the manufacturer and marketer to NPPA. - regarding
326 Implementation of prices fixed and notified under the provisions of DPCO, 2013 - reg.
327 Revision of ceiling price due to revision of WPI.
328 Revision of ceiling price by National Pharmaceutical Pricing Authority (NPPA)
329 corrigendum-Hiring of consultants on contract basis
330 Hiring of Technical consultant and Legal consultant on contract
331 Hiring of consultants on contract basis
332 Major achievements during March,2017- IC Section
333 Guidelines for hiring of consultant on contract basis
334 Public notice as decided in the first meeting of the Committee for ensuring enhanced accessibility of drugs to the poor held on 6.4.2017
335 Medical Device Manufacturing in India-a Sunrise
336 Committee for ensuring enhanced accessibility of Drugs to the poor-regarding
337 Minutes of 27th Steering Committee Meeting
338 Tender Notice For Comprehensive AMC of Computers, Laptops, Printers, Servers, UPS, Router & Switch Pins installed in the offices of NPPA
    339 Hiring of ONE DLY AC vehicle in NPPA on monthly basis
      340 Major achievements during February, 2017 – IC Section
      341 Letter to Manufacturer for compliance of the pricing capping of the Coronary Stents
      342 List of 2nd Pharma/Medical Device Awards
      343 Grant-in-aid under Pharmaceuticals Promotion & Development Scheme (PPDS) for preparing “Calendar of Events’’ for the financial year 2017-18
      344 Major achievements by Ministries/Departments
      345 Information on emoluments being paid to Consultants- Regarding
      346 Information on emoluments being paid to Consultants- Regarding
      347 Major achievements by Department of Pharmaceuticals
      348 Published notification regarding stents
      349 EOI for research study
      350 Shortage of Pencillamine medicine used for treatment of Wilson s disease- Meeting Notice Regarding

      Pages